Why is Biohaven Ltd. stock down today?
June 23, 2026
Biohaven Ltd.
BHVN · NYQ · USD
vs. prev. close $15.5
Last updated Jun 23, 2026 15:13
Intraday Chart — 5-min intervals
BHVN · less than a minute ago
Biohaven Ltd. dips 1.42% — Insider Monkey reports
Biohaven Ltd. (BHVN) is trading lower, at $15. 28 — down 1. 42% from yesterday's close of $15. 50. Today's move appears driven by recent headlines, including "Biohaven (BHVN) Climbs 14% Higher Ahead of New Clinical Trials" and "Pfizer (PFE) CFO Dave Denton to Step Down Effective August 15". News sentiment around BHVN is leaning mixed.
The broader market is under pressure (S&P 500: -1. 1%, Nasdaq: -1. 7%, Dow Jones: +0. 0%, Shanghai: +1. 8%, Hang Seng: -1. 8%). Past performance does not guarantee future results.
Key Factors
Auto-generated analysis · Not financial advice
Biohaven (BHVN) Climbs 14% Higher Ahead of New Clinical Trials
Insider Monkey·about 13 hours agoneutralPfizer (PFE) CFO Dave Denton to Step Down Effective August 15
Insider Monkey·2 days agoneutralPfizer CFO Dave Denton stepping down in August 2026
Quartz·5 days agoneutralPfizer Announces Chief Financial Officer Transition
Business Wire·5 days agoneutralBiohaven (BHVN) Climbs 12.66% Ahead of Pipeline Updates
Insider Monkey·6 days agoneutralRapport ‘fully prepared’ to launch seizure drug solo, CEO says
BioPharma Dive·11 days agoneutralIs Biohaven (BHVN) Quietly Reframing Its Investment Story Around Brain Energy and Precision Immunology?
Simply Wall St.·15 days agoneutralBiohaven (BHVN) Valuation Check After New R&D Milestones In Immunology Neuroscience And Metabolic Programs
Simply Wall St.·16 days agoneutral
S&P 500
-1.13%
Nasdaq
-1.73%
Dow Jones
+0.01%
Shanghai
+1.78%
Hang Seng
-1.82%
Nikkei 225
-3.55%
FTSE 100
+0.19%
Nifty 50
-1.16%
DAX
-0.74%
OMX Stockholm
-0.82%
Search another stock